Effectiveness of Methanol Extract of Moringa oleifera Lam. Leaf as Antibacterial Drug to Bacterial Triggers of Urinary Tract Infections In vitro
Evy Suryani Arodes, Jap Mai Cing, Fransiska Sitompul, Linggom Kurniaty, Lusia Sri Sunarti, Forman Erwin Siagian
Journal of Complementary and Alternative Medical Research · pp. 1–12 · Published 5 Jan 2022
10.9734/jocamr/2022/v17i130321Abstract
Background: Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus. High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections. This study aimed to measure the lowest concentration of Moringa oleifera Lam. Leaf that did not show any growth of the tested microorganisms. Methods: The antibacterial activity test was adapted from the CLSI broth microdilution assay, with minor modifications, were used for the evaluation of the antibacterial activity of M. oleifera extracts against tested bacteria. Three concentrations higher than the MIC standard were cultured on the MHA. The lowest concentration on agar which was not found any growth of the bacterial colonies was determined as the MBC. Results: The antibacterial activity test results showed that Moringa leaf extract could inhibit bacterial growth. Inhibition of bacterial growth based on extract concentration. For E. coli bacteria, the results showed the highest absorbance value at 100mg/ml concentration (2.86±0.02); even when diluted to 3,13 mg/ml (1.08±0.01), the moringa leaf extracts could inhibit the E. coli growth, although the value did not differ greatly from that of the negative control (0.13±0.06). The same as E. coli, the antibacterial activity test results showed that moringa leaf extract could inhibit others bacteria growth of UTIs. Conclusions: Methanol extract of Moringa oleifera leaf can inhibit and bactericide the growth of urinary tract infections bacteria.
Cited by 4
Shifat Fatima, M. A. Usmani, Arvind K. Srivastava · Research pharmaceutica · 2024
Beniam Worku, Nafyad Tolossa · Oxidative Medicine and Cellular Longevity · 2024
Karima Gharsallah, L. Rezig, M. Rajoka · South African Journal of Botany · 2023
Hubza Ruatt Khan, M. Javeed, Iqra Batool · Journal of Bioresource Management · 2023
Related research
- Asymptomatic Bacteriuria among Pregnant Women at University Hospital in Uyo, Nigeria: Prevalence, Risk Factors and Characteristics — shares topic coverage
- Urine Analysis and Determination of Drug Sensitivity Pattern of Isolated Escherichia coli from Urinary Tract Infected Patients — shares topic coverage
- Efficacy of Nitrofurantoin and Fosfomycin against Extended Spectrum Beta Lactamase Producing Uropathogens in the Era of Antibiotic Resistance: A Cross-sectional Study — shares topic coverage
- Prevalence and Microbial Resistance of Uropathogenic Bacteria Isolated from Neonatal and Pediatric Patients in Western of Iran — shares topic coverage
- Epidemiology and Sensitivity to Antibiotics of Uropathogenic Bacteria in Patients at the CHU Ignace Deen National Hospital in Conakry, Guinea — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
4
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.